1Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystie ovarian disease. J Clin Endocrinol Matab, 1980,50:113～ 116.
2Dunaif A,Halfman AR,Scully RE,et al. The clinical ,biochemical,and ovarian morphologic features in women with acanthosis nigrican and musculinication. Obster Gynecol, 1985,66: 545～552.
3Vandermolen DT, Ratts VS, Evans WS. Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomophene citrate alone. Fertil Steril, 2001,75 (2): 310～ 315.
4Glueck CJ ,Phillips H,Cameron D. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first trimester spontaneous abortion: a pilot study.Fertil Steril, 2001,75 (1): 46～52.
5Dunaif A. Insulin resistance and the polycystic ovary syndrome:mechanism and implication for pathogenesis. Endocr Rev, 1997,18:774～800.
3Nestler JE. Role of hypefirtsulinemia in the pathologenesis of polycystic ovary syndrome, and its clinical implication [ J]. Semia Reprod Engdocrinol,1997,15 (2) :111-122.
4Vandermolen DT, Ratts VS, Evans WS. Mefform in increase the ovulatory rate and pregnancy rate from elomiphene citrate in patients with polyeystie ovary syndrome who are resistant to clomophene cirate alone[ J]. Fertil Steril,2001,75 (2) :310-315.
7Hohe J. Polycystlc ovary syndrome and insulin resistance thrifty genes struggling with over feeding and sedentary life style [ J ]. J Endo Invest, 1998,21 (9) :589-601.
